CVS Health Intersegment Elimination — Operating Income increased by 121.6% to $4.68B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.7%, from $3.37B to $4.68B. Over 4 years (FY 2021 to FY 2025), Intersegment Elimination — Operating Income shows a downward trend with a -23.1% CAGR.
Significant changes indicate shifts in internal pricing strategies or the volume of intercompany trade.
This represents the net impact of all intersegment eliminations on the company's operating income. It reconciles the sum...
Standard reconciliation item in segment reporting for all diversified conglomerates.
cvs_segment_intersegment_elimination_operating_income_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.33B | $3.06B | $2.35B | $3.55B | $4.67B | -$3.92B | $3.66B | $3.45B | $3.23B | $3.69B | $3.37B | $2.27B | $3.05B | $832.00M | $2.37B | $3.37B | $2.38B | -$3.21B | $2.11B | $4.68B |
| QoQ Change | — | -29.2% | -23.4% | +51.1% | +31.7% | -183.9% | +193.4% | -5.8% | -6.2% | +14.1% | -8.6% | -32.7% | +34.1% | -72.7% | +184.6% | +42.5% | -29.4% | -234.7% | +165.9% | +121.6% |
| YoY Change | — | — | — | — | +7.9% | -228.0% | +56.0% | -2.8% | -30.7% | +194.2% | -7.8% | -34.1% | -5.8% | -77.5% | -29.8% | +48.6% | -21.8% | -485.5% | -10.8% | +38.7% |